Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Glaxo Boosts Production of Antiviral Medication

By Pharmaceutical Processing | May 1, 2009

RESEARCH TRIANGLE PARK, N.C. (AP) — GlaxoSmithKline, the world’s second-largest drugmaker, said Friday it has boosted production of antiviral medication as the U.S. government reported two dozen additional cases of swine flu. The London-based company said it is ramping up operations to be able to produce about 5 million packs of Relenza per month, but it will take 12 to 14 weeks to get to that level. Relenza is one of two antiviral drugs that make up the U.S. government’s stockpile of 44 million courses of antiviral medication. The other drug is Tamiflu, made by Swiss drugmaker Roche. Glaxo said in a statement it is in discussions with other drugmakers about further increasing its capacity. The company said it has also been in touch with the World Health Organization, the Centers for Disease Control and other health bodies about possible development of a vaccine for swine flu. “GSK stands ready to begin manufacture of a potential vaccine against the new influenza A strain virus once the WHO and other public health authorities make recommendations for composition of the vaccine,” the company said.

Related Articles Read More >

Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE